NASDAQ · Healthcare · Biotechnology
MannKind Corporation
MNKD
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. CEO Michael E. Castagna · Market cap $1.1B.
$3.55
-0.01 · -0.28%
52w hi $6.5152w lo $2.23
Off 52w high 58.5%
59
ROUTINE
Current InsiderScore
Corp · 90d
1
1 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
0
0 strong · 0 notable
Analyst consensus
Strong Buy
Avg PT $7.00
Section 01
Recent Form 4 filings
1 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Mar 10 | Michael Castagna | Chief Executive Officer | Buy | 100,000 | $2.59 | +$259K | 59 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay